Dr Murdoc Khaleghi Appointed CMO at Base

To Support Expanded Personalized Biomarker Testing and Health Recommendations

Dr Murdoc Khaleghi is a founding member of the Everlywell team and serves as Medical Director at several health tech startups including WellnessFX, Healium, NeuroTrack, and Me Biosciences.

Dr Murdoc Khaleghi will oversee testing operations, address medical questions from users and help identify new critical health biomarkers to expand the company’s consumer products.

“We are thrilled to add Dr. Khaleghi to our growing team at Base. His impressive background will help boost our medical team, as well as advance our mission to bridge the gap between science and consumers,” said Lola Priego, Founder and CEO of Base. “With his expertise, we aim to create an all encompassing support system for people looking to take control of their health through prevention and personalization.”

Base launched in February 2021 after months of beta testing with $3.4M in seed funding and has experienced tremendous growth since, due in part to the consumer shift to embrace at-home and personalized healthcare. The company uses advanced technology to analyze a blood or saliva sample to determine hormone, vitamin and nutrient deficiencies and address health concerns in five key areas; diet, stress, energy, sleep and sex drive. A diagnosis is then delivered to users via the Base app, along with data-driven suggestions to improve any biomarker levels that are sub-optimal. Personalized recommendations span nutrition, supplement, and lifestyle changes

Last month, the company integrated with Amazon to further advance the personalized health experience and allow users to tailor their shopping choices based on their health goals and lab results. The recommended vitamins and supplements can be added to users’ Amazon shopping cart straight from the Base app, and are vetted and approved by the medical team, which is now led by Dr. Khaleghi.

“Having worked in diagnostics for more than a decade, I have witnessed the power of biomarker testing for overall health improvement and research within the space,” said Dr. Khaleghi. “I’m excited to join Base and work alongside Lola, a passionate and forward-thinking visionary, to continue providing individuals the tools and resources to make informed decisions about their health.”

SourceBase

Hot this week

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”

Avery Dennison Medical Introduces Ipdated SilFoam Lite: Sustainability, MDR Certification & Performance Improvements

The newly enhanced SilFoam Lite delivers superior efficiency and reliability, bringing improved fluid handling capabilities and improved tack. These improvements make the product ideal for customers seeking quality, high-performance solutions in wound care notes Avery Dennison Medical.

Voluntary Recall Notifying Medtronic Insulin Pump Users of Potential Risks of Shortened Pump Battery Life

Medtronic plc voluntarily issued a field action starting on July 31, 2024, notifying global customers of its MiniMed™ 600 series or 700 series insulin pumps to follow their pump's built-in alerts and alarms for battery status and to contact Medtronic if they observe changes in the battery life of their pump

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."